Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2014 · limited liability company

$1.6bn reported value -25.3% vs Q1 2024
35positions
64.6%in top 10
6 new 6 added 3 reduced 9 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APOGEE THERAPEUTICS INC COM COM 8,493,321 $334.2m21.28% 21.28% UnchangedShares held: Q3 2023 8.5m, Q4 2023 8.5m, Q1 2024 8.5m, Q2 2024 8.5m
2 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 4,026,331 $94.1m5.99% 5.99% UnchangedShares held: Q3 2023 3.0m, Q4 2023 3.0m, Q1 2024 4.0m, Q2 2024 4.0m
3 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 4,400,000 $92.4m5.88% 5.88% UnchangedShares held: Q3 2023 3.0m, Q4 2023 3.4m, Q1 2024 4.4m, Q2 2024 4.4m
4 OCULAR THERAPEUTIX INC COM OCUL OCUL 12,762,462 $87.3m5.56% 5.56% UnchangedShares held: Q3 2023 0, Q4 2023 7.8m, Q1 2024 12.8m, Q2 2024 12.8m
5 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $76.7m4.89% 4.89% UnchangedShares held: Q3 2023 2.2m, Q4 2023 2.2m, Q1 2024 2.2m, Q2 2024 2.2m
6 MERUS N V COM MRUS MRUS 1,263,214 $74.7m4.76% 4.76% ReducedShares held: Q3 2023 1.7m, Q4 2023 2.1m, Q1 2024 1.8m, Q2 2024 1.3m -527.0k -527,000 -29.4%
7 KALVISTA PHARMACEUTICALS INC COM KALV KALV 6,249,731 $73.6m4.69% 4.69% UnchangedShares held: Q3 2023 2.9m, Q4 2023 4.1m, Q1 2024 6.2m, Q2 2024 6.2m
8 PHARVARIS N V COM PHVS PHVS 3,395,606 $63.8m4.07% 4.07% UnchangedShares held: Q3 2023 1.6m, Q4 2023 3.4m, Q1 2024 3.4m, Q2 2024 3.4m
9 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 2,685,448 $63.1m4.02% 4.02% AddedShares held: Q3 2023 0, Q4 2023 2.4m, Q1 2024 2.2m, Q2 2024 2.7m +513.7k +513,666 23.6%
10 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 2,094,373 $54.2m3.45% 3.45% UnchangedShares held: Q3 2023 927.7k, Q4 2023 927.7k, Q1 2024 2.1m, Q2 2024 2.1m
11 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,882,671 $50.5m3.22% 3.22% UnchangedShares held: Q3 2023 3.1m, Q4 2023 3.9m, Q1 2024 3.9m, Q2 2024 3.9m
12 COGENT BIOSCIENCES INC COM COGT COGT 5,684,167 $47.9m3.05% 3.05% AddedShares held: Q3 2023 4.7m, Q4 2023 4.7m, Q1 2024 5.1m, Q2 2024 5.7m +555.0k +555,000 10.8%
13 APPLIED THERAPEUTICS INC COM APLT APLT 9,542,871 $44.6m2.84% 2.84% AddedShares held: Q3 2023 5.7m, Q4 2023 6.2m, Q1 2024 9.1m, Q2 2024 9.5m +467.9k +467,871 5.2%
14 ERASCA INC COM ERAS ERAS 16,216,216 $38.3m2.44% 2.44% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 16.2m
15 ASTRIA THERAPEUTICS INC COM CATB CATB 3,608,645 $32.8m2.09% 2.09% UnchangedShares held: Q3 2023 0, Q4 2023 3.2m, Q1 2024 3.6m, Q2 2024 3.6m
16 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 1,818,182 $32.7m2.09% 2.09% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.8m, Q2 2024 1.8m
17 ORIC PHARMACEUTICALS INC COM ORIC ORIC 4,394,527 $31.1m1.98% 1.98% UnchangedShares held: Q3 2023 2.1m, Q4 2023 2.4m, Q1 2024 4.4m, Q2 2024 4.4m
18 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 706,131 $29.2m1.86% 1.86% AddedShares held: Q3 2023 0, Q4 2023 353.6k, Q1 2024 706.1k, Q2 2024 706.1k +5 +5 0.0%
19 ENGENE HOLDINGS INC COM COM 2,825,983 $26.6m1.70% 1.70% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.6m, Q2 2024 2.8m +260.1k +260,142 10.1%
20 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,379,965 $24.1m1.53% 1.53% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.4m
21 TERNS PHARMACEUTICALS INC COM COM 3,410,058 $23.2m1.48% 1.48% UnchangedShares held: Q3 2023 3.1m, Q4 2023 4.5m, Q1 2024 3.4m, Q2 2024 3.4m
22 MERSANA THERAPEUTICS INC COM COM 11,328,000 $22.8m1.45% 1.45% UnchangedShares held: Q3 2023 11.3m, Q4 2023 11.3m, Q1 2024 11.3m, Q2 2024 11.3m
23 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 6,023,166 $21.1m1.34% 1.34% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 6.0m
24 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 9,000,000 $20.2m1.28% 1.28% UnchangedShares held: Q3 2023 14.4m, Q4 2023 10.4m, Q1 2024 9.0m, Q2 2024 9.0m
25 ABIVAX SA SPONSORED ADS ABVX ABVX 1,345,780 $17.8m1.13% 1.13% UnchangedShares held: Q3 2023 0, Q4 2023 998.6k, Q1 2024 1.3m, Q2 2024 1.3m
26 ARVINAS INC COM ARVN ARVN 627,788 $16.7m1.06% 1.06% UnchangedShares held: Q3 2023 0, Q4 2023 627.8k, Q1 2024 627.8k, Q2 2024 627.8k
27 AQUESTIVE THERAPEUTICS INC COM AQST AQST 5,555,555 $14.4m0.92% 0.92% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 5.6m, Q2 2024 5.6m
28 CENTURY THERAPEUTICS INC COM IPSC IPSC 5,389,259 $13.7m0.88% 0.88% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 3.4m, Q2 2024 5.4m +2.0m +1,984,126 58.3%
29 CABALETTA BIO INC COM CABA CABA 1,563,952 $11.7m0.75% 0.75% UnchangedShares held: Q3 2023 2.0m, Q4 2023 2.6m, Q1 2024 1.6m, Q2 2024 1.6m
30 TREVI THERAPEUTICS INC COM TRVI TRVI 3,422,637 $10.2m0.65% 0.65% ReducedShares held: Q3 2023 3.4m, Q4 2023 3.4m, Q1 2024 3.4m, Q2 2024 3.4m -38 -38 0.0%
31 ADVERUM BIOTECHNOLOGIES INC COM NEW ADVM ADVM 1,467,048 $10.1m0.64% 0.64% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.6m, Q2 2024 1.5m -89.4k -89,371 -5.7%
32 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 750,000 $7.5m0.48% 0.48% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 750.0k
33 TENAYA THERAPEUTICS INC COM TNYA TNYA 1,555,556 $4.8m0.31% 0.31% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.6m, Q2 2024 1.6m
34 ARCA BIOPHARMA INC COM COM 866,375 $3.3m0.21% 0.21% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 866.4k
35 CASI PHARMACEUTICALS INC ORD SHS CASIF CASIF 111,686 $614.3k0.04% 0.04% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 111.7k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
HILLEVAX INC 2,075,000 $34.5m2.1m shares
CELCUITY INC CELC CELC 970,000 $21.0m970.0k shares
IMMATICS N.V IMTX IMTX 1,750,000 $18.4m1.8m shares
LYRA THERAPEUTICS INC LYRA LYRA 2,576,093 $16.0m2.6m shares
CG ONCOLOGY INC CGON CGON 350,000 $15.4m350.0k shares
MINERALYS THERAPEUTICS INC MLYS MLYS 555,554 $7.2m555.6k shares
ACELYRIN INC 937,113 $6.3m937.1k shares
EYEPOINT PHARMACEUTICALS INC EYPT EYPT 250,000 $5.2m250.0k shares
OLEMA PHARMACEUTICALS INC OLMA OLMA 77,042 $872.1k77.0k shares